Related references
Note: Only part of the references are listed.Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity
Gabriel K. Griffin et al.
NATURE (2021)
Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity
Hai Hu et al.
CANCER IMMUNOLOGY RESEARCH (2021)
SETDB1 promotes the progression of colorectal cancer via epigenetically silencing p21 expression
Nan Cao et al.
CELL DEATH & DISEASE (2020)
Visualizing and interpreting cancer genomics data via the Xena platform
Mary J. Goldman et al.
NATURE BIOTECHNOLOGY (2020)
Multiple pathways of type 1 interferon production in lupus: the case for amlexanox
Ian Todd et al.
RHEUMATOLOGY (2020)
Hypoxia induces rapid changes to histone methylation and reprograms chromatin
Michael Batie et al.
SCIENCE (2019)
HIF Inhibitors: Status of Current Clinical Development
Jaleh Fallah et al.
CURRENT ONCOLOGY REPORTS (2019)
Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
Matthew E. Cockmann et al.
ELIFE (2019)
Molecular landmarks of tumor hypoxia across cancer types
Vinayak Bhandari et al.
NATURE GENETICS (2019)
SETDB1 regulates SMAD7 expression for breast cancer metastasis
Tae Young Ryu et al.
BMB REPORTS (2019)
JmjC histone demethylases act as chromatin oxygen sensors
Michael Batie et al.
MOLECULAR & CELLULAR ONCOLOGY (2019)
Emerging role of SETDB1 as a therapeutic target
Archana Venkataramana Karanth et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Silencing of retrotransposons by SET DB1 inhibits the interferon response in acute myeloid leukemia
Trinna L. Cuellar et al.
JOURNAL OF CELL BIOLOGY (2017)
The Dfam database of repetitive DNA families
Robert Hubley et al.
NUCLEIC ACIDS RESEARCH (2016)
Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs
Roger M. Phillips
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Histone H3K9 methylation is dispensable for Caenorhabditis elegans development but suppresses RNA:DNA hybrid-associated repeat instability
Peter Zeller et al.
NATURE GENETICS (2016)
ATF7IP-Mediated Stabilization of the Histone Methyltransferase SETDB1 Is Essential for Heterochromatin Formation by the HUSH Complex
Richard T. Timms et al.
CELL REPORTS (2016)
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli et al.
CELL (2015)
Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53
Qi Fei et al.
NATURE COMMUNICATIONS (2015)
Transcriptional landscape of repetitive elements in normal and cancer human cells
Steven W. Criscione et al.
BMC GENOMICS (2014)
Transcriptional regulation by hypoxia inducible factors
Veronica L. Dengler et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis
M. Rodriguez-Paredes et al.
ONCOGENE (2014)
HAX1 regulates E3 ubiquitin ligase activity of cIAPs by promoting their dimerization
Jin Sun Choi et al.
ONCOTARGET (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
RNA-Seq analysis in MeV
Eleanor A. Howe et al.
BIOINFORMATICS (2011)
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset
Craig J. Ceol et al.
NATURE (2011)
Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
F. M. Buffa et al.
BRITISH JOURNAL OF CANCER (2010)
SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state
Steve Bilodeau et al.
GENES & DEVELOPMENT (2009)
Erythrocytosis-associated HIF-2α Mutations Demonstrate a Critical Role for Residues C-terminal to the Hydroxylacceptor Proline
Paul W. Furlow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Hypoxia induces a novel signature of chromatin modifications and global repression of transcription
Amber Buescher Johnson et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK
Beichu Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Redox sensor CtBP mediates hypoxia-induced tumor cell migration
Qinghong Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
JmjC-domain-containing proteins and histone demethylation
Robert J. Klose et al.
NATURE REVIEWS GENETICS (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Effects of hypoxia on the proliferation and differentiation of NSCs
LL Zhu et al.
MOLECULAR NEUROBIOLOGY (2005)
Molecular basis of the VHL hereditary cancer syndrome
WG Kaelin
NATURE REVIEWS CANCER (2002)
SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins
DC Schultz et al.
GENES & DEVELOPMENT (2002)
HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
F Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Share Paper
